Wellmedr vs Enhance MD: Pricing, Compounds, and Guarantees

Quick verdict: Wellmedr emphasizes lifetime locked-in pricing, dose-stable plans, and same-day review while Enhance MD emphasizes low first-month semaglutide pricing and flat-rate pricing that does not rise with dose. This comparison focuses on pricing structure, compound options and labeling, guarantees and shipping, clinician review and patient volume.

See Wellmedr plans and pricing

Wellmedr vs Enhance MD: how they differ

Both platforms offer clinician-directed GLP-1 programs using compounded medications, but the providers differ in starting rates, pricing guarantees, and how they present branded products. Below are the most distinctive supported differences drawn from each provider’s published claims.

1. Pricing headline and starting rates

Wellmedr advertises GLP-1 plans with messaging like “GLP-1 Plans Starting at Just $89/Month” while also listing semaglutide monthly plans “Starting At $49 a month” in product details. Enhance MD clearly advertises semaglutide “from $49” for the first month and tirzepatide “from $99” for the first month, noting those are the lowest first-month prices for the compounds.

2. Ongoing pricing policy and escalation

Wellmedr markets “Lifetime locked-in pricing” and “No dose-based price increases,” presenting a promise that pricing will not increase based on dose. Enhance MD emphasizes flat-rate pricing meaning “the same price at every dose, with no fee escalation during titration,” but notes the $49/$99 rates are introductory first-month prices and ongoing flat rates can be higher.

3. Compounded medications and branded products

Both providers use compounded GLP-1 medications and include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety or effectiveness. Wellmedr states it offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies and also lists branded items such as Ozempic and Zepbound with prices, noting these entries contain semaglutide or tirzepatide in their descriptions. Enhance MD states it prescribes compounded semaglutide and tirzepatide and explicitly notes it does not offer branded finished products.

4. Guarantees, shipping, and extras

Wellmedr promotes same-day review, free overnight shipping, an on-time refills guarantee, and marketing claims including a money-back guarantee tied to weight-loss in 90 days in its captured landing-page evidence. Enhance MD highlights cost-focused features such as up to $150 off the first order and metabolic lab testing every six months in some published pricing tables.

Comparison table: direct side-by-side

Criteria	Wellmedr	Enhance MD
Advertised starting price	GLP-1 plans starting at $89/mo; semaglutide listed “Starting At $49 a month”	Semaglutide from $49 first month; tirzepatide from $99 first month
Ongoing pricing policy	Lifetime locked-in pricing; no dose-based price increases	Flat-rate pricing: same price at every dose after introductory period; first-month rates are lower
Compounded or branded	Offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies; lists branded items in pricing copy	Offers compounded semaglutide and tirzepatide; notes no branded finished products
Guarantees and shipping	Claims same-day review, free overnight shipping, on-time refills, and a money-back weight-loss guarantee in landing copy	Offers up to $150 off first order and includes metabolic lab testing every six months in pricing tables
Volume and experience	Not supplied	States 10,000+ patients treated

5. Clinician review and eligibility

Both require a licensed clinician to determine medical appropriateness and state that treatment is available only after clinician review. Wellmedr explicitly notes all treatment plans require medical evaluation and clinician approval. Enhance MD describes a clinician-directed review process and also notes treatment is available only when a clinician determines it is medically appropriate.

View Enhance MD first-month offers

How to choose between Wellmedr and Enhance MD

Use the comparison focus areas above. If your top priorities are a marketed lifetime locked-in price, claims of no dose-based price increases, and same-day review with overnight shipping, the published evidence supports Wellmedr’s positioning. If your priority is the lowest first-month entry cost for semaglutide or access to both compounded semaglutide and tirzepatide with an explicit flat-rate approach after introduction, Enhance MD’s published claims emphasize those features.

Check Wellmedr’s GLP-1 plans

Compare Enhance MD pricing

Start enrollment with Wellmedr

Final notes and safety reminders

Both providers’ materials include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Wellmedr and Enhance MD both state treatment is subject to clinician review. The article does not supply information on insurance, explicit state coverage, or long-term clinical outcomes beyond the providers’ captured claims.

Choose one based on evidence

Choose Wellmedr if you prioritize lifetime locked-in pricing, no dose-based price increases, and same-day review with overnight shipping as presented in Wellmedr’s published claims.

Choose Enhance MD if you prioritize the lowest first-month semaglutide or tirzepatide entry prices and a published flat-rate pricing model that keeps the same price at every dose after the introductory period.